(Q38077226)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sebastian Furness

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Arthur Christopoulos

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Patrick M. Sexton

series ordinal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

6

Laurence J Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

Cassandra Koole

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

Emilia E Savage

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Kavita Pabreja

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

Biochemical Society Transactions

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

172-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23356279%20AND%20SRC:MED&resulttype=core&format=json

Global estimates of the prevalence of diabetes for 2010 and 2030

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Chemistry and biochemistry of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Molecular mechanisms underlying nutrient detection by incretin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Molecular basis of glucagon-like peptide 1 docking to its intact receptor studied with carboxyl-terminal photolabile probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Characterization of glucagon-like peptide-1 receptor-binding determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

New treatments in type 2 diabetes: a focus on the incretin-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Incretin hormone mimetics and analogues in diabetes therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Once-weekly GLP-1 agonists: How do they differ from exenatide and liraglutide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Biological activity of AC3174, a peptide analog of exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Small-molecule agonists for the glucagon-like peptide 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236

Allosteric modulation of endogenous metabolites as an avenue for drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120236